Experimental Section
Chemicals 4-(2-Hydroxyethyl)piperazine-1-ethanesulfonic acid (HEPES) sodium salt, 2-(NMorpholino)ethanesulfonic acid (MES) sodium salt, potasium chloride, magnesium chloride, 6-monodeoxy-6-monoamino-β-cyclodextrin hydrochloride (β-CD), crown ether (CE), 4-(phenyldiazenyl)benzoic acid, N-Boc-1,2-diamioethane, carboxymethylcellulose (CMC), 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC), N-hydroxysulfosuccinimide (NHS), N-hydroxysulfosuccinimide (sulfo-NHS), trifluoracetic acid (TFA), dimethylformamide (DMF), dichloroform (DCM) and methanol (MeOH) were purchased from Sigma-Aldrich. Gel Red was purchased from Biotium, Inc., USA. Gel Red was purchased from Biotium, Inc., USA. 5' end aminno modified nucleic acid strands were purchased from Integrated DNA Technologies Inc. (Coralville, IA). Tetramethylrhodamine-dextran (70 kDa MW), Amplex Red, resorufin and hemin were purchased from Life Technologies Corporation. Ultrapure water purified by a NANOpure Diamond instrument (Barnstead International, Dubuque, IA, USA). Table S1 . Sequences of the DNA strands 
Measurement
The absorbance were recorded by a UV-2450 spectrophotometer (Shimadzu). 1 H NMR and DOSY spectra were performed by using a Bruker Ultrashield Plus 400 MHz spectrometer. SEM images were taken by using Extra High-Resolution Scanning Electron Microscope Magellan (TM) 400L, microscope. The hydrogel sample was frozen by immersing in liquid nitrogen. The frozen sample was dried through lyophilization and then placed on the slides (Si) and further coated by Au. The mechanical properties and cross-linking kinetics was analyzed by a HAAKE MARS III rheometer (Thermo Scientific).
Synthesis
Scheme S1. The synthesis of (N-aminoethyl p-carboxamide)-trans-azobenzene
The synthesis of compound (1) Azobenzoic acid (213 mg, 1 mmol) was dissolved in DMF at 60 ℃. NHS (230 mg, 2 mmol), EDC· HCl (382 mg, 2 mmol) and a catalytic amount of DMAP were added to the solution. The reaction was stirred overnight. Pure water was added to the solution and red precipitate was obtained and filtered. The solid was dried to yield product 1 (284 mg, 0.88 mmol, 88% The synthesis of compound (2) 1 (64.6 mg, 0.2 mmol) was dissolved in dried DCM, and N-Boc-1,2-diamioethane (63.2 L, 0.4 mmol) was added into the solution to stir for 2 h at room temperature. After 2 h, the solvent was evaporated and the crude product was dissolved in DCM and was chromatographed (silica gel, DCM: MeOH = 10:1) to yield 2 (0.042 g, 43% The synthesis of compound (3) 2 (41.4 mg, 0.11 mmol) was dissolved DCM (3 mL) and TFA (0.5 mL) was added dropwise at 0 ℃ into the solution. The mixture was stirred at room temperature for 2 h. After 2 h, the solvent was evaporated to yield the purified product 3 (26.8 mg, 0.1 mmol, 90% 
Synthesis of β-CD functionalized CMC ploymer
CMC (10 mg, 410 -8 mol) was dissolved in 1 ml MES buffer solution (10 mM, pH = 5.5). EDC (10 mg, 510 -5 mol) was added into the solution and incubated for 5 min, then sulfo-NHS (13 mg, 610 -5 mol) was added and incubated for 10 min. Then β-CD (8.5 mg, 710 -6 mol) dissolved in HEPES buffer (10 mM, pH = 7.0) was added and the mixture was stirred for 4 h. The modified polymer was separated using a MWCO 100K spin filter (Amicon) for three times. The separated polymer was lyophilized overnight to yield the white powder.
Synthesis of azobenzene functionalized CMC ploymer
CMC (10 mg, 410 -8 mol) was dissolved in 1 ml MES buffer solution (10 mM, pH = 5.5). EDC (10 mg, 510 -5 mol) was added into the solution and incubated for 5 min, then sulfo-NHS (13 mg, 610 -5 mol) was added and incubated for 10 min. Then compound 3 (2.5 mg, 810 -6 mol) was dissolved in DMF (40 L) and added to the solution and the mixture was stirred for 4 h. The resulted mixture was lyophilized overnight and the modified polymer was separated using a MWCO 100K spin filter (Amicon). The separated polymer was lyophilized overnight to yield the yellow powder.
Functionalization of the CMC polymer with the DNA duplex tethers (1)
CMC (10 mg, 410 -8 mol) was dissolved in 1 ml MES buffer solution (pH = 5.5). EDC (10 mg, 510 -5 mol) was added into the solution and incubated for 5 min, then sulfo-NHS (13 mg, 610 -5 mol) was added and incubated for 10 min. Then HEPES buffer solution (50 mM, pH = 7.0) that included the DNA duplex tethers (1) (310 -7 mol) was added into the solution to react for 4 h. The modified polymer was separated using a MWCO 100K spin filter (Amicon). The separated polymer was lyophilized overnight to yield the functionalized white powder.
Functionalization of the CMC polymer with the half G-quadruplex tethers (2)
CMC (10 mg, 410 -8 mol) was dissolved in 1 ml MES buffer solution (pH = 5.5). EDC (10 mg, 510 -5 mol) and sulfo-NHS (13 mg, 610 -5 mol) were added into the solution and incubated for 5 min. Then HEPES buffer solution (50 mM, pH = 7.0) that included the half G-quadruplex units (2) (1.210 -6 mol) was added into the solution to react for 4 h. The modified polymer was separated using a MWCO 100K spin filter (Amicon). The separated polymer was lyophilized overnight to yield the functionalized white powder.
Preparation of the hydrogel crosslinked by self-complementary nucleic acid (1) and β-CD/azobenzene bridges and the switchable transitions between different states
The DNA (1)/ β-CD functionalized polymer (2 mg) and DNA (1)/ azobenzene functionalized polymer (2 mg) were dissolved in in a HEPES buffer solution (10 mM, MgCl2, 100 mM, pH = 7.0) to yield a polymer solution containing 1 mM of (1). The solution was heated to 90˚ and then transferred into the triangle-shaped mold. After keeping it overnight to form a hydrogel, the hydrogel was extruded from the mold and treated with UV light and visible light for 10 min and 10 min, respectively, to trigger the switchable transitions between low stiffness and high stiffness states.
Preparation of the hydrogel crosslinked by G-quadruplex (2) and β-CD/azobenzene bridges and the switchable transitions between three states
The DNA (2)/ β-CD functionalized polymer (2 mg) and DNA (2)/ azobenzene functionalized polymer (2 mg) were dissolved in in a HEPES buffer solution (10 mM, MgCl2, 100 mM, pH = 7.0) that contains KCl (0.2 M) to yield a polymer solution with 1.32 mM of (2). The solution was heated to 90˚ and then transferred into the triangleshaped mold. After keeping it overnight to form a hydrogel, the hydrogel was extruded from the mold and treated with UV light and visible light for 10 min and 10 min, respectively, to trigger the switchable transitions between low stiffness and high stiffness states. Similarly, the hydrogel was treated with CE (0.2 M, 100 µl) and K + (0.2 M, 100 µl) for 4 h to trigger the switchable transitions between low stiffness and high stiffness states.
Calculation of hydrogel area
Using Image-Pro Plus software, we can select the colored region of hydrogels or quasiliquid states, measure the pixels of the selected regions and export measurements to statistical and spreadsheet package.
Preparation of TMR-dextran loaded hydrogel crosslinked by G-quadruplex (2) and β-CD/azobenzene bridges and the release of TMR-dextran
The DNA (2)/ β-CD functionalized polymer (2 mg) and DNA (2)/ azobenzene functionalized polymer (2 mg) were dissolved in in a HEPES buffer solution (10 mM, MgCl2, 100 mM, pH = 7.0) that contains KCl (0.2 M) and TMR-dextran (0.2 mg/mL of) to yield a polymer solution with 1.32 mM of (2). The solution was heated to 90˚ and then kept overnight to form a hydrogel. The hydrogel was treated with UV light for 10 min to trigger the release of TMR-dextran. Similarly, the hydrogel was treated with CE (0.2 M, 100 µl) to trigger the release of TMR-dextran.
Binding/unbinding of G-quadruplex in the hydrogel crosslinked by G-quadruplex (2) and β-CD/azobenzene bridges
The DNA (2)/ β-CD functionalized polymer (2 mg) and DNA (2)/ azobenzene functionalized polymer (2 mg) were dissolved in in a HEPES buffer solution (10 mM, MgCl2, 100 mM, pH = 7.0) that contains KCl (0.2 M) and hemin (50 M). The solution was heated to 90˚ and then kept overnight to form a hydrogel. Immersion of the hydrogel in the HEPES buffer that contains Amplex Red (5 M), and then measure the fluorescence of the buffer. In addition, after treatment of the hydrogel with 18-crown-6-ether, immerse the hydrogel in the HEPES buffer that contains Amplex Red (5 M) and measure the fluorescence change. 
